This conclusion is supported by the following evidence: (1) the mRNA levels of STARD13-correlated ceRNAs are significantly downregulated in both breast CSC subpopulation sorted by cell surface stemness markers and breast cancer spheres; (2) STARD13-correlated ceRNA network inhibits CSC traits of breast cancer in vitro and in vivo; and (3) our previous study has shown that STARD13-correlated ceRNA network activity is a clinically relevant tool to predict the proclivity to develop metastasis and EMT, itself another hallmark of CSC activity [15]. Here, STARD13 is linked to breast cancer.